BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 11181677)

  • 1. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
    Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K
    J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
    Nakamura H; Horita S; Senmaru N; Miyasaka Y; Gohda T; Inoue Y; Fujita M; Meguro T; Morita T; Nagashima K
    Oncol Rep; 2002; 9(4):751-5. PubMed ID: 12066203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma.
    Salmela MT; Karjalainen-Lindsberg ML; Puolakkainen P; Saarialho-Kere U
    Br J Cancer; 2001 Aug; 85(3):383-92. PubMed ID: 11487270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
    Schwandner O; Schlamp A; Broll R; Bruch HP
    Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.
    Jones LE; Humphreys MJ; Campbell F; Neoptolemos JP; Boyd MT
    Clin Cancer Res; 2004 Apr; 10(8):2832-45. PubMed ID: 15102692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
    Määttä M; Soini Y; Liakka A; Autio-Harmainen H
    Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of metalloproteinases and their inhibitors in pancreatic cancer].
    Łukaszewicz M; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw (Online); 2008 Apr; 62():141-7. PubMed ID: 18414340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis.
    Matsuno K; Adachi Y; Yamamoto H; Goto A; Arimura Y; Endo T; Itoh F; Imai K
    J Gastroenterol; 2003; 38(4):348-54. PubMed ID: 12743774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix-degrading metalloproteinases in tumor progression.
    Matrisian LM; Wright J; Newell K; Witty JP
    Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
    Adachi Y; Yamamoto H; Itoh F; Arimura Y; Nishi M; Endo T; Imai K
    Int J Cancer; 2001 Sep; 95(5):290-4. PubMed ID: 11494227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.
    Giannopoulos G; Pavlakis K; Parasi A; Kavatzas N; Tiniakos D; Karakosta A; Tzanakis N; Peros G
    Anticancer Res; 2008; 28(3B):1875-81. PubMed ID: 18630474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma.
    Bister V; Skoog T; Virolainen S; Kiviluoto T; Puolakkainen P; Saarialho-Kere U
    Mod Pathol; 2007 Nov; 20(11):1128-40. PubMed ID: 17873896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic significance of the molecular markers in human gastrointestinal cancer].
    Itoh F; Imai K
    Rinsho Byori; 2003 Feb; 51(2):158-67. PubMed ID: 12690634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer.
    Hilska M; Roberts PJ; Collan YU; Laine VJ; Kössi J; Hirsimäki P; Rahkonen O; Laato M
    Int J Cancer; 2007 Aug; 121(4):714-23. PubMed ID: 17455256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer.
    Michael M; Babic B; Khokha R; Tsao M; Ho J; Pintilie M; Leco K; Chamberlain D; Shepherd FA
    J Clin Oncol; 1999 Jun; 17(6):1802-8. PubMed ID: 10561218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
    Yamamoto H; Horiuchi S; Adachi Y; Taniguchi H; Nosho K; Min Y; Imai K
    Carcinogenesis; 2004 Mar; 25(3):325-32. PubMed ID: 14604892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.